Verflixt! Es sieht so aus, als wenn Sie einen veralteten Browser benutzen. Wir empfehlen Ihnen dringend Ihren Browser zu aktualisieren.
Weitere Informationen über Browser und Updates finden Sie hier

Baxter Innovations GmbH

Baxter is a global healthcare company that assists healthcare professionals and patients with treatment of complex medical conditions.

Baxter’s BioScience business is a leader in recombinant and plasma-based protein replacement therapies to treat hemophilia and other bleeding disorders; plasma-based therapies to treat immune deficiencies, alpha 1-antitrypsin deficiency, burns and shock, and other chronic and acute blood-related conditions; products for regenerative medicine, such as biosurgery products and technology used in adult stem-cell therapies; and vaccines.

BioScience core business units include: Hemophilia, Biotherapeutics, Regenerative Medicine and Vaccines. BioScience products represent approximately 44 percent of Baxter’s annual sales, totaling $5.3 billion in 2008.

Details


Adresse:
Baxter Innovations GmbH

Industriestraße 67
1221 Wien
Österreich
Arbeitsgebiet:
Forschung & Lehre
Expansion:
international
Webseite:
Mitarbeiteranzahl:
mehr als 500